what happens if i stop taking ghk cu GHK-Cu Side Effects: Does the Research Say? Doctor Explains ghk cu vs glow vs

10.1177/154405910408300612 99 LvX.YangY.HanS.LiD.TuH.LiW.et al (2015)

effects stop when drug stops

Hypothetical Conservative Combination Protocol A conservative approach to combining these peptides would likely involve: Phase 1: Tirzepatide Establishment (Weeks 1-12) Week 1-4: Tirzepatide 2.5 mg weekly Week 5-8: Tirzepatide 5 mg weekly Week 9-12: Tirzepatide 7.5 mg weekly Cagrilintide: None (establish baseline tolerance) Phase 2: Cagrilintide Introduction (Weeks 13-20) Week 13-16: Tirzepatide 7.5 mg + Cagrilintide 0.6 mg weekly Week 17-20: Tirzepatide 7.5 mg + Cagrilintide 1.2 mg weekly Phase 3: Optimization (Week 21+) Tirzepatide 10-12.5 mg + Cagrilintide 2.4 mg weekly Adjust based on tolerance and response "The key principle when considering any peptide combination is sequential introduction with careful monitoring of tolerability markers, particularly gastrointestinal symptoms that could compound across mechanisms." This theoretical framework prioritizes safety through staged introduction, though actual clinical protocols would require medical supervision and monitoring

Researchers working with sensitive skin models should begin with once-daily application and monitor for local reactions before increasing frequency

Animal and cell studies show promise in areas like fertility and ovarian support, yet human trials remain sparse